EUVIMEDOpdag EUVIMED
Systematische ÜbersichtMetaanalyseOpen access · CC BY-NC-ND 4.0

Oncological and reproductive outcomes of endometrial atypical hyperplasia and endometrial cancer patients undergoing conservative therapy with hysteroscopic resection: A systematic review and meta‐analysis

Shuangshuang Zhao, Jingying Zhang, Ye Yan, Lina Tian, Lingli Chen, Xingyu Zheng, Yiqing Sun, Wenyan Tian, Fengxia Xue, Yingmei Wang iD

Acta Obstetricia et Gynecologica Scandinavica · 2024-08 · 103 (8) · 1498-1512

DOI: 10.1111/aogs.14815 ↗

At a glance

Systematische Übersicht in Acta Obstetricia et Gynecologica Scandinavica, published online on 2024-02-21. Written by Shuangshuang Zhao and 9 co-authors. Institution: Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin, China. Major MEDLINE topics: Endometrial Neoplasms, Hysteroscopy, Endometrial Hyperplasia, Conservative Treatment. Cited 23 times so far (Crossref); 44 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: China Anti-Cancer Association-Hengrui PARP Nicotinamide Cancer Research Fund, Tianjin Municipal Health Commission, National Natural Science Foundation of China.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Introduction

Our objective was to conduct a systematic review and meta‐analysis of studies evaluating the oncological and reproductive outcomes of patients with endometrial atypical hyperplasia (AH) and endometrioid endometrial cancer (EEC) undergoing conservative therapy with hysteroscopic resection (HR). Material and methods This study followed the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) statement for systematic reviews and meta‐analyses. The study strictly followed the methodological framework proposed by the Cochrane Handbook and was retrospectively registered in PROSPERO (CRD42023469986). Searches were conducted in PubMed, Embase, and the Cochrane Library, from inception to October 10, 2023. A checklist based on items of the Newcastle–Ottawa Scale and the Methodological Index for Non‐randomized Studies was used for quality assessment. The primary end points for this meta‐analysis were complete response (CR), pregnancy, and live birth rates following HR‐based therapy in patients with EEC or AH. The secondary end point was the recurrence rate (RR).

Results

Twenty‐one articles involving 407 patients with clinical stage IA, low or intermediate grade, EEC, and 444 patients with AH managed with HR‐based conservative treatment were included for this systematic review. CR to HR‐based conservative therapy was achieved in 88.6% of patients with EEC and 97.0% of patients with AH. Of these, 30.6% and 24.2%, respectively, had live births. The overall pooled disease RR was 18.3% and 10.8% in patients with EEC and AH, respectively. Further subset analyses revealed that EEC patients with body mass index (BMI) ≤28 kg/m 2 had higher CR rates as well as higher chances of pregnancy and live birth (91.6% CR, 32.9% pregnancy, 31.1% live birth) compared with patients with BMI >28 kg/m 2 (86.4% CR, 28.4% pregnancy, 23.0% live birth). The HR followed by oral progestogen subgroup had higher CR rates and higher chances of pregnancy and live birth (91.8% CR, 36.3% pregnancy, 28.2% live birth) than the HR followed by the levonorgestrel intrauterine system subgroup (82.5% CR, 25.3% pregnancy, 16.3% live birth).

Conclusions

Hysteroscopic resection followed by progestins appears to be a promising choice for fertility‐sparing treatment in young patients with AH and EEC, with effective and safe responses. The live birth rate remains to be improved by providing medical guidance and encouragement.

Subjects

MeSH terms (MEDLINE)

Endometrial NeoplasmsHysteroscopyEndometrial HyperplasiaConservative TreatmentHumansFemalePregnancyPregnancy Rate

Author keywords

conservative therapyendometrial atypical hyperplasiaendometrial cancerfertility‐sparinghysteroscopic resection

Authors and institutions

  • Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin, China.
  • Tianjin Key Laboratory of Female Reproductive Health and Eugenics, Tianjin Medical University General Hospital, Tianjin, China.

ORCID profiles: Yingmei Wang

Funding

  • China Anti-Cancer Association-Hengrui PARP Nicotinamide Cancer Research Fund
  • Tianjin Municipal Health Commission
  • National Natural Science Foundation of China
  • Key Technologies Research and Development Program

Cite

APA

Zhao, S., Zhang, J., Yan, Y., Tian, L., Chen, L., Zheng, X., Sun, Y., Tian, W., Xue, F., & Wang, Y. (2024). Oncological and reproductive outcomes of endometrial atypical hyperplasia and endometrial cancer patients undergoing conservative therapy with hysteroscopic resection: A systematic review and meta‐analysis. Acta Obstetricia et Gynecologica Scandinavica, 103(8), 1498-1512. https://doi.org/10.1111/aogs.14815

Vancouver

Zhao S, Zhang J, Yan Y, Tian L, Chen L, Zheng X, et al. Oncological and reproductive outcomes of endometrial atypical hyperplasia and endometrial cancer patients undergoing conservative therapy with hysteroscopic resection: A systematic review and meta‐analysis. Acta Obstetricia et Gynecologica Scandinavica. 2024;103(8):1498-1512. doi:10.1111/aogs.14815

BibTeX
@article{Zhao2024,
  author = {Zhao, Shuangshuang and Zhang, Jingying and Yan, Ye and Tian, Lina and Chen, Lingli and Zheng, Xingyu and Sun, Yiqing and Tian, Wenyan and Xue, Fengxia and Wang, Yingmei},
  title = {Oncological and reproductive outcomes of endometrial atypical hyperplasia and endometrial cancer patients undergoing conservative therapy with hysteroscopic resection: A systematic review and meta‐analysis},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2024},
  volume = {103},
  number = {8},
  pages = {1498--1512},
  doi = {10.1111/aogs.14815}
}
Start for free →